Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced or metastatic ovarian epithelial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of the Ovary
• Ovarian Epithelial Cancer
• Ovarian Neoplasm

Drugs mentioned

• Ocoxin®-Viusid®

Snippet

Sponsor: Catalysis SL | Conditions: Carcinoma, Ovarian Neoplasm | Phase 2 | Status: COMPLETED